Vanguard Group Discloses 1% Stake in Life Science REIT plc

The Vanguard Group, Inc. has released its Form 8.3 disclosure, indicating its interest in Life Science REIT plc. The disclosure, dated 17 March 2025, reveals a 1% holding, equivalent to 3,517,143 ordinary shares. These positions are in accordance with Rule 8.3 of the Takeover Code, which mandates transparency for entities with stakes of 1% or more in relevant securities.

Vanguard's disclosure specifies no other parties involved or related dealings beyond Life Science REIT plc. There are no agreements or arrangements related to options or derivatives, as confirmed by sections declaring "none." The information was submitted by Shawn Acker, ensuring compliance with regulatory requirements for market transparency.